Enanta Pharmaceuticals To Present Phase 2 Data For Zelicapavir In RSV Showing Faster Symptom Resolution And Lower Hospitalization At ESCMID Global 2026

Benzinga Newsdesk www.benzinga.com Positive 93.7%